Business Context and Reporting Period
Company: Capricor Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date: March 10, 2020
Event: Regulation FD Disclosure regarding a corporate presentation posted to the company website updating investors on current business and products.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the availability of a corporate presentation (Exhibit 99.1) and does not contain a financial statement or earnings release.
Material Changes
No material financial changes or operational metrics are detailed within the text of this filing. The document references an attached presentation for business updates but does not summarize those changes in the filing body.
Guidance, Outlook, and Risks
Management Commentary: The company issued a corporate presentation to update stakeholders on its business and products.
Legal Status: The information in Item 7.01 is furnished and not deemed "filed" under Section 18 of the Exchange Act, meaning it is not subject to the liabilities of that section unless expressly incorporated by reference in another filing.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Corporate Presentation) for specific details on business updates and product status.
- Verify the company's current cash position and burn rate in the most recent 10-Q or 10-K, as this 8-K does not contain financial data.
- Confirm the trading status of Common Stock (Symbol: CAPR) on The Nasdaq Capital Market.